Regioselective enzymatic acylation of aureolic acids to obtain novel analogues with improved antitumor activity

Advanced Synthesis and Catalysis

Volumn 354, Issue 8, 2012, Pages 1500-1508

  González Sabín, Javier ^a   Núñez, Luz Elena ^a   Braña, Alfredo F ^b   Méndez, Carmen ^b   Salas, José A ^b   Gotor, Vicente ^c   Morís, Francisco ^a  

^a EntreChem SL   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c UNIVERSITY OF OVIEDO   (Spain)

Author keywords

antitumor antibiotics; aureolic acids; biocatalysis; lipases; mithramycin; regioselective acylation

Indexed keywords

EID: 84861561399     PISSN: 16154150     EISSN: 16154169     Source Type: Journal    
DOI: 10.1002/adsc.201100944     Document Type: Article

References (23)

1. F. Lombõ, N. Menéndez, J. A. Salas, C. Méndez, Appl. Microbiol. Biotechnol. 2006, 73, 1-14.
2. M. A. Mir, S. Majee, S. Das, D. Dasgupta, Bioorg. Med. Chem. 2003, 11, 2791-2801.
3. W. A. Remers, in: The Chemistry of Antitumor Antibiotics, Wiley-Interscience, New York, 1979, Vol. 1, pp 133- 175
4. J. D. Skarbek, M. K. Speedie, in: Antitumor Compounds of Natural Origin, CRC Press, Boca Raton, Florida, 1981, Vol. 1, pp 191- 235.
5. Y. Gao, Z. Jia, X. Kong, Q. Li, D. Z. Chang, D. Wei, X. Le, H. Suyun, S. Huang, L. Wang, K. Xie, Cancer Res. 2011, 71, 5182-5193.
6. N. Osada, Y. Kosuge, S. Oguchi, H. Miyagishi, K. Ishige, Y. Ito, Neurochem Int. 2012, 60, 47-54.
7. A. N. Tevyashova, E. N. Zbarsky, J. Balzarini, A. A. Shtil, L. G. Dezhenkova, V. M. Bukhman, V. B. Zbarsky, M. N. Preobrazhenskaya, J. Antibiot. 2009, 62, 37-41.
8. L. L. Remsing, A. M. González, M. Nur-e-Alam, M. Fernández-Lozano, A. F. Braña, U. Rix, M. A. Oliveira, C. Méndez, J. A. Salas, J. Rohr, J. Am. Chem. Soc. 2003, 125, 5745-5753
9. V. Albertini, A. Jain, S. Vignati, S. Napoli, A. Rinaldi, I. Kwee, M. Nur-e-Alam, J. Bergant, F. Bertoni, G. M. Carbone, J. Rohr, C. Catapano, Nucleic Acids Res. 2006, 34, 1721-1734
10. S. Previdi, A. Malek, V. Albertini, C. Riva, C. Capella, M. Broggini, G. M. Carbone, J. Rohr, C. Catapano, Gynecol. Oncol. 2010, 118, 182-188.
11. N. Menéndez, M. Nur-e-Alan, A. F. Braña, J. Rohr, J. A. Salas, C. Méndez, Mol. Microbiol. 2004, 53, 903-915.
12. B. García, J. González-Sabín, N. Menéndez, A. F. Braña, L. E. Núñez, F. Morís, J. A. Salas, C. Méndez, Microbial Biotechnol. 2011, 4, 226-238.
13. A. S. Bommarius, B. R. Riebel, Biocatalysis, Wiley-VCH, Weinheim, 2004
14. S. Riva, Curr. Opin. Chem. Biol. 2001, 5, 106-111.
15. P. Cesti, A. Zaks, A. M. Klibanov, Appl. Biochem. Biotechnol. 1985, 11, 401-407.
16. R. Ikan, Naturally Occurring Glycosides, John Wiley & Sons, Chichester, 1999.
17. J. González-Sabín, R. Morán-Ramallal, F. Rebolledo, Chem. Soc. Rev. 2011, 40, 5321-5335.
18. Combinatorial biocatalysis, introduced by Dordick and Clark in 1996, is an emerging technology which uses enzymes and microbial catalysts to generate libraries through iterative biotransformations of lead compounds. For a representative review, see:, D. H. Altreuter, D. S. Clark, Curr. Opin. Biotech., 1999, 10, 130-136. For some examples, see
19. F. Secundo, G. Carrea, M. De Amici, S. J. Di Ventimiglia, J. S. Dordick, Biotechnol. Bioeng. 2003, 81, 391-396
20. J. O. Rich, C. L. Budde, L. D. McConeghey, I. C. Cotterill, V. Mozhaev, S. B. Singh, M. A. Goetz, A. Zhao, P. C. Michels, Y. L. Khmelnitsky, Bioorg. Med. Chem. Lett. 2009, 19, 3059-3062.
21. M. R. Boyd, K. D. Paull, Drug Dev. Res. 1995, 34, 91-109
22. R. H. Shoemaker, Nature Reviews 2006, 6, 813- 823
23. F. Barcelõ, M. Ortiz-Lombardía, M. Martorell, M. Oliver, C. Méndez, J. A. Salas, J. Portugal, Biochemistry 2010, 49, 10543-10552.